e-learning
resources
Stockholm 2002
Tuesday 17.09.2002
Pathophysiology of interstitial and vascular lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Is cathepsin K a protective factor in the development of lung fibrosis?
F. Bühling, A. Gerber, C. Röcken, T. Welte (Magdeburg, Germany)
Source:
Annual Congress 2002 - Pathophysiology of interstitial and vascular lung diseases
Session:
Pathophysiology of interstitial and vascular lung diseases
Session type:
Thematic Poster Session
Number:
3016
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Bühling, A. Gerber, C. Röcken, T. Welte (Magdeburg, Germany). Is cathepsin K a protective factor in the development of lung fibrosis?. Eur Respir J 2002; 20: Suppl. 38, 3016
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
From pulmonary gas exchange to the interpretation of arterial blood gases
The physiology of breathlessness
Respiratory physiology
Related content which might interest you:
A role for cathepsin S in the pathogenesis of cystic fibrosis lung disease?
Source: Annual Congress 2011 - Cell biology of lung disease
Year: 2011
Potential role of cathepsin S in bleomycin-induced lung fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 729s
Year: 2005
The role of cathepsin S in lung disease
Source: International Congress 2018 – Proteases: at the cutting edge of lung disease
Year: 2018
Targeting of cathepsin S reduces cystic fibrosis-like lung disease
Source: Eur Respir J, 53 (3) 1801523; 10.1183/13993003.01523-2018
Year: 2019
Cathepsin S as a mediator of acute lung inflammation
Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of COPD
Year: 2019
Evidence that cathepsin G counteracts the profibrotic effects of neutrophil elastase following lung injury
Source: Eur Respir J 2001; 18: Suppl. 33, 181s
Year: 2001
Cathepsins in bleomycin-induced lung injury in rat
Source: Eur Respir J 2003; 22: 427-435
Year: 2003
Activated protein C protection in endotoxin-induced lung injury is mediated by lung matrix metalloproteinases activity
Source: Annual Congress 2007 - Miscellaneous lower respiratory tract infections
Year: 2007
The role of cathepsin S in the development of inflammation in patients with severe bronchial asthma
Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough
Year: 2021
Growth factor regulation of lung fibrosis lessons from other organs
Source: Annual Congress 2006 - Scientific year in review
Year: 2006
Lysosomal cysteine proteases in the lung: role in protein processing and immunoregulation
Source: Eur Respir J 2004; 23: 620-628
Year: 2004
The role of matrix metalloproteinases in cystic fibrosis lung disease
Source: Eur Respir J 2011; 38: 721-727
Year: 2011
MMP expression and abnormal lung permeability are important determinants of outcome in IPF
Source: Eur Respir J 2009; 33: 77-84
Year: 2009
Increased alveolar soluble annexin V promotes lung inflammation and fibrosis
Source: Eur Respir J 2015; 46: 1417-1429
Year: 2015
Regulation of alternative macrophage activation by galectin-3; potential role in lung fibrosis
Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease?
Year: 2009
Antifibrotic role of hepatocyte growth factor (HGF) in fibrosing interstial lung diseases
Source: Eur Respir J 2001; 18: Suppl. 33, 367s
Year: 2001
Correlation between tenascin C and tissue factor in patients with interstitial lung disease
Source: Eur Respir J 2003; 22: Suppl. 45, 83s
Year: 2003
Role of Bcl-xL in hepatocyte growth factor elicited epithelial protection in idiopathic lung fibrosis
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: pathogenesis
Year: 2013
Inhibition of airway proteases in cystic fibrosis lung disease
Source: Eur Respir J 2008; 32: 783-795
Year: 2008
A neutrophil elastase inhibitor prevents bleomycin-induced pulmonary fibrosis in mice
Source: Eur Respir J 2012; 40: 1475-1482
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept